Related Experiment Video
Updated: Jun 25, 2026

Novel Apparatus and Method for Drug Reinforcement
Published on: August 20, 2010
Use of supervised injection facilities and injection risk behaviours among young drug injectors
María J Bravo1, Luis Royuela, Luis De la Fuente
1Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain. mbravop@isciii.es
Aims:
To study the use of supervised injection facilities (SIFs) as a predictor of safer injecting practices.
Design:
Cross-sectional study conducted with face-to-face interview using a structured questionnaire with computer-assisted personal interviewing. Dried blood spot samples were collected for human immunodeficiency virus (HIV) and hepatitis C virus (HCV) antibody testing.
Setting:
All participants were street-recruited by chain referral methods in Madrid and Barcelona.
Participants:
A total of 249 young heroin drug injectors recruited by the ITINERE cohort study in two Spanish cities with SIFs.
Measurements:
The main outcome measures were self-reported injecting behaviours and SIFs attendance.
Results:
SIF users were more marginalized socially than non-users. They were also more often regular injectors (weekly or more versus sporadic) [odds ratio (OR) = 4.9, 95% confidence interval (CI): 2.7-8.8], speedball users (OR = 2.5, 95% CI: 1.5-4.3) and anti-HCV-positive (OR = 3.1, 95% CI: 1.4-7.1). In the logistic regression analysis, using SIFs was associated independently with not borrowing used syringes (OR = 3.3, 95% CI: 1.4-7.7). However, no significant association was found between SIF use and not sharing injection equipment indirectly (OR = 1.1, 95% CI: 0.5-2.2).
Conclusions:
SIFs attract highly disadvantaged drug injectors who engage none the less in less borrowing of used syringes than non-users of these facilities. The risks of indirect sharing should be emphasized when counselling SIF attendees.
More Related Videos
Related Concept Videos
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Prevention of Further Absorption of Poison
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Pharmaceutical Poisoning: Potential Scenarios

